Diagnostics

Curium Completes the Acquisition of Monrol as Part of its Plan to Significantly Expand Lutetium-177 Capacity and PET FootprintCurium Completes the Acquisition of Monrol as Part of its Plan to Significantly Expand Lutetium-177 Capacity and PET Footprint

Curium Completes the Acquisition of Monrol as Part of its Plan to Significantly Expand Lutetium-177 Capacity and PET Footprint

Positions Curium as leading manufacturer of Lu-177 isotopeBrings innovative R&D expertise and pipeline to Curium Enhances Curium’s SPECT & PET…

4 days ago
Spectral AI Announces 2024 Fourth Quarter and Full Year Financial ResultsSpectral AI Announces 2024 Fourth Quarter and Full Year Financial Results

Spectral AI Announces 2024 Fourth Quarter and Full Year Financial Results

2024 Research & Development Revenue of $30 Million Successful Results from the US Burn Validation Study On Track for Regulatory…

4 days ago
Single-cell Analysis Market Surges to USD 5.4 Billion by 2033, Propelled by 9.5% CAGR – Verified Market Reports®Single-cell Analysis Market Surges to USD 5.4 Billion by 2033, Propelled by 9.5% CAGR – Verified Market Reports®

Single-cell Analysis Market Surges to USD 5.4 Billion by 2033, Propelled by 9.5% CAGR – Verified Market Reports®

The Single-Cell Analysis Market is experiencing robust expansion, driven by surging demand for precision medicine, advancements in genomics, and rising investments…

5 days ago
Oragenics, Inc. Provides Q1 2025 Shareholder Update on Strategic and Financial ProgressOragenics, Inc. Provides Q1 2025 Shareholder Update on Strategic and Financial Progress

Oragenics, Inc. Provides Q1 2025 Shareholder Update on Strategic and Financial Progress

ONP-002 Advances Toward Phase IIa Concussion Trial with Strengthened Financial Foundation and Industry MomentumSARASOTA, Fla., March 27, 2025 (GLOBE NEWSWIRE)…

5 days ago
ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025

ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025

GARDEN CITY, NY, March 27, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next…

5 days ago
Chan Zuckerberg Initiative Announces New Biohub to Develop Breakthrough Imaging Technologies to Observe Cells in ActionChan Zuckerberg Initiative Announces New Biohub to Develop Breakthrough Imaging Technologies to Observe Cells in Action

Chan Zuckerberg Initiative Announces New Biohub to Develop Breakthrough Imaging Technologies to Observe Cells in Action

The CZ Biohub San Francisco and CZ Imaging Institute will join together to develop novel imaging technologies that provide entirely…

6 days ago
Ascential Medical & Life Sciences Announces Executive Leadership Changes to Drive Strategic GrowthAscential Medical & Life Sciences Announces Executive Leadership Changes to Drive Strategic Growth

Ascential Medical & Life Sciences Announces Executive Leadership Changes to Drive Strategic Growth

Ellen Scipta and Chris Cowen join the organization as CFO and CCO, respectively, while Todd Martensen transitions from CCO to…

6 days ago
Medrio Enhances RTSM For Faster Clinical Trial Starts and Greater FlexibilityMedrio Enhances RTSM For Faster Clinical Trial Starts and Greater Flexibility

Medrio Enhances RTSM For Faster Clinical Trial Starts and Greater Flexibility

SAN FRANCISCO, March 26, 2025 /PRNewswire/ -- Medrio, a global leader in clinical trial technology, today announced enhancements to its randomization…

6 days ago
Lunit to Present AI Study on EGFR Mutation Prediction in NSCLC at AACR 2025 in Collaboration with AstraZenecaLunit to Present AI Study on EGFR Mutation Prediction in NSCLC at AACR 2025 in Collaboration with AstraZeneca

Lunit to Present AI Study on EGFR Mutation Prediction in NSCLC at AACR 2025 in Collaboration with AstraZeneca

AI-powered model predicts EGFR mutations from H&E-stained slides, demonstrating robust performance across diverse clinical settings and helping overcome barriers to…

6 days ago
Rarecells Inc. Appoints Dr. Neil Kurtz to Board of DirectorsRarecells Inc. Appoints Dr. Neil Kurtz to Board of Directors

Rarecells Inc. Appoints Dr. Neil Kurtz to Board of Directors

NEW YORK and PARIS, March 26, 2025 /PRNewswire/ -- Rarecells Inc., a pioneering company in liquid biopsy technology, is pleased…

6 days ago